, Feb. 21 -- In 2024, two distinct grand jury panels, representing 16 countries, will judge this year's entries.

These juries will review submissions from each exclusive designation, providing both panels with the opportunity to comprehensively evaluate the world of healthcare and pharma advertising.

NYF Heath's grand jury includes a diverse roster of award-winning leaders recruited from top-tier agencies spanning six continents.

Renowned for their award-winning contributions, the grand jury comprises some of the most visionary minds in healthcare advertising.

The 2024 juries' commitment to excellence and diverse perspectives guarantees that entrants' work will be carefully evaluated with the highest level of dedication and thoughtful...